Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Q301--NEW - VCB Lung Cancer Screening Reference Lab

U.S. Department Of Veterans Affairs·Texas

Q301--NEW - VCB Lung Cancer Screening Reference Lab

Closes 4/27/2026$10k – $50kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a Firm-Fixed priced contract to Biodesix, Inc., for the procurement of lung cancer screening laboratory services. The services include Nodify XL2 and Nodify CDT testing, with a quantity of 10 each. The contract is for the Pathology and Laboratory Medicine Service of the Texas VA Valley Coastal Bend Healthcare System in McAllen, Harlingen, and Corpus Christi, Texas. Only blood draw collection method will be allowed. * The contract is for a sole source procurement, with the government intending to negotiate with only one source, Biodesix, Inc. * The proposed contract actions are for supplies, with the anticipated statutory authorities permitting other than full and open competition. * The contract will be made by a pricing agreement with Biodesix, Inc. * The notice is not a request for quotations or proposals, but all responsible sources may submit a capability statement, proposal, or quotation, which will be considered by the agency.

Attached files

Contact

Delphia Schoenfeld(Contracting Officer)

[email protected]

(210) 417-7495

Key dates

Opened
4/13/2026
Closes
4/27/2026

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
621511
Solicitation №
36C25726Q0461

Budget estimate

$10,000 – $50,000

The budget for this contract is not explicitly stated in the document. However, based on the quantities of the testing services mentioned (10 each of Nodify XL2 and Nodify CDT), it can be estimated that the budget will be in the range of $10,000 to $50,000. This estimate is rough and may vary depending on the pricing agreement with Biodesix, Inc. The factors that may influence the likely payment range include the cost of the testing services, the pricing agreement with the contractor, and the government's budget for the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Veterans Affairs·New Jersey

Top match · 74%

Q301--Reference and Esoteric Laboratory Testing

Closes 11/30/2026Opened 10/30/2026

U.S. Department Of Veterans Affairs·Illinois

70% match

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Closes 11/3/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

68% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

Mental Health, NYS Office of·New York

67% match

IFB 26-067 FLU/PCR, CT/NG PCR and HCV/PCR Testing

Closes 12/3/2026Opened 10/16/2026

U.S. Department Of Veterans Affairs·Georgia

67% match

EMERGENT REFERENCE LAB TESTING

Closes 11/19/2026Opened 11/13/2025

U.S. National Institutes of Health·United States of America

66% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

66% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. National Institutes of Health·United States of America

66% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

65% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. Department Of Veterans Affairs·Florida

65% match

6632--FY27 Microbial Incubation ID and Susceptibility CPT

Closes 11/10/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

65% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

65% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

65% match

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Closes 5/27/2027Opened 6/24/2026

Colorado Department of Public Health and Environment·Colorado

65% match

NBS Laboratory Information Management System - OIT

Closes 11/2/2026Opened 9/30/2026

South Coast Air Quality Management District·California

65% match

Continuous Total Volatile Organic Compound (TVOC) Monitor

Closes 11/3/2026Opened 10/2/2026

U.S. National Institutes of Health·United States of America

65% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

65% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. Department Of Veterans Affairs·New York

65% match

6550--Sources Sought: Tuberculosis Testing Reagents and Consumables for the Buffalo VA Medical Center. In support of the Tuberculosis (TB) Testing Program

Closes 11/12/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

65% match

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Closes 2/3/2027Opened 4/1/2024

U.S. Department Of Homeland Security·United States of America

65% match

Bottle Liquid Scanner (BLS) Qualified Products List (QPL)

Closes 11/15/2026Opened 10/14/2026

Massachusetts Department of Public Health·Massachusetts

64% match

RFR 257030 Certified Oncology Data Specialist

Closes 6/30/2030Opened 3/6/2025

Colorado Department of Public Health and Environment – Laboratory Services Division – Newborn Screening Program·Colorado

64% match

NBS Laboratory Information Management System - OIT

Closes 11/2/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

64% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025